Logo image of MARR.MI

MARR SPA (MARR.MI) Stock Fundamental Analysis

BIT:MARR - Euronext Milan - IT0003428445 - Common Stock - Currency: EUR

10  +0.06 (+0.6%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MARR. MARR was compared to 24 industry peers in the Consumer Staples Distribution & Retail industry. MARR has only an average score on both its financial health and profitability. MARR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MARR was profitable.
MARR had a positive operating cash flow in the past year.
Of the past 5 years MARR 4 years were profitable.
Of the past 5 years MARR 4 years had a positive operating cash flow.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.89%, MARR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Return On Equity of MARR (17.16%) is better than 70.83% of its industry peers.
MARR has a better Return On Invested Capital (9.87%) than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MARR is below the industry average of 9.60%.
The last Return On Invested Capital (9.87%) for MARR is above the 3 year average (6.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.89%
ROE 17.16%
ROIC 9.87%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

MARR's Profit Margin of 1.93% is in line compared to the rest of the industry. MARR outperforms 54.17% of its industry peers.
In the last couple of years the Profit Margin of MARR has declined.
MARR has a Operating Margin (3.27%) which is comparable to the rest of the industry.
MARR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 7.73%, MARR is doing worse than 91.67% of the companies in the same industry.
In the last couple of years the Gross Margin of MARR has grown nicely.
Industry RankSector Rank
OM 3.27%
PM (TTM) 1.93%
GM 7.73%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MARR is still creating some value.
The number of shares outstanding for MARR has been reduced compared to 1 year ago.
The number of shares outstanding for MARR has been reduced compared to 5 years ago.
Compared to 1 year ago, MARR has about the same debt to assets ratio.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

The Debt to FCF ratio of MARR is 18.55, which is on the high side as it means it would take MARR, 18.55 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 18.55, MARR is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.00 indicates that MARR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.00, MARR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 18.55
Altman-Z N/A
ROIC/WACC1.55
WACC6.36%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.62 indicates that MARR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.62, MARR belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
MARR has a Quick Ratio of 1.13. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MARR (1.13) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.13
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

MARR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.26%.
Measured over the past years, MARR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.05% on average per year.
Looking at the last year, MARR shows a decrease in Revenue. The Revenue has decreased by -0.32% in the last year.
MARR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)-15.26%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-260.38%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%-2.26%

3.2 Future

MARR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.54% yearly.
Based on estimates for the next years, MARR will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue Next Year3.05%
Revenue Next 2Y3.37%
Revenue Next 3Y3.97%
Revenue Next 5Y3.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

MARR is valuated reasonably with a Price/Earnings ratio of 11.11.
Based on the Price/Earnings ratio, MARR is valued a bit cheaper than 75.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of MARR to the average of the S&P500 Index (27.45), we can say MARR is valued rather cheaply.
A Price/Forward Earnings ratio of 12.31 indicates a correct valuation of MARR.
MARR's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, MARR is valued a bit cheaper.
Industry RankSector Rank
PE 11.11
Fwd PE 12.31
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MARR.
MARR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.27
EV/EBITDA 8
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y11.57%
EPS Next 3Y11.54%

6

5. Dividend

5.1 Amount

MARR has a Yearly Dividend Yield of 6.62%, which is a nice return.
MARR's Dividend Yield is rather good when compared to the industry average which is at 4.01. MARR pays more dividend than 91.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, MARR pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.62%

5.2 History

The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

66.73% of the earnings are spent on dividend by MARR. This is not a sustainable payout ratio.
DP66.73%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (7/3/2025, 7:00:00 PM)

10

+0.06 (+0.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-04 2025-08-04
Inst Owners23.6%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap665.30M
Analysts78.33
Price Target12.56 (25.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.62%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP66.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.38%
PT rev (3m)-3.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 11.11
Fwd PE 12.31
P/S 0.22
P/FCF 26.27
P/OCF 11.81
P/B 1.95
P/tB 3.87
EV/EBITDA 8
EPS(TTM)0.9
EY9%
EPS(NY)0.81
Fwd EY8.12%
FCF(TTM)0.38
FCFY3.81%
OCF(TTM)0.85
OCFY8.47%
SpS45.65
BVpS5.13
TBVpS2.58
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.89%
ROE 17.16%
ROCE 14.13%
ROIC 9.87%
ROICexc 12.63%
ROICexgc 18.27%
OM 3.27%
PM (TTM) 1.93%
GM 7.73%
FCFM 0.83%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
ROICexc(3y)9.5%
ROICexc(5y)7.64%
ROICexgc(3y)14.76%
ROICexgc(5y)12.13%
ROCE(3y)9.43%
ROCE(5y)7.37%
ROICexcg growth 3Y-2.5%
ROICexcg growth 5Y-13.81%
ROICexc growth 3Y0.65%
ROICexc growth 5Y-11.99%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
F-Score4
Asset Turnover2.54
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 18.55
Debt/EBITDA 2.78
Cap/Depr 135.35%
Cap/Sales 1.02%
Interest Coverage 250
Cash Conversion 46.11%
Profit Quality 43.24%
Current Ratio 1.62
Quick Ratio 1.13
Altman-Z N/A
F-Score4
WACC6.36%
ROIC/WACC1.55
Cap/Depr(3y)107.37%
Cap/Depr(5y)94.25%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.26%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-260.38%
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%-2.26%
Revenue Next Year3.05%
Revenue Next 2Y3.37%
Revenue Next 3Y3.97%
Revenue Next 5Y3.62%
EBIT growth 1Y-20.16%
EBIT growth 3Y7.4%
EBIT growth 5Y-6.98%
EBIT Next Year52.54%
EBIT Next 3Y22.77%
EBIT Next 5YN/A
FCF growth 1Y326.05%
FCF growth 3Y-31.25%
FCF growth 5Y-12.02%
OCF growth 1Y832.14%
OCF growth 3Y-19.18%
OCF growth 5Y-3.88%